$59.70-1.13 (-1.86%)
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally.
Exponent, Inc. in the Industrials sector is trading at $59.70 with a market capitalization of $2.8B. Wall Street consensus targets $81.67 (3 analysts), implying a +36.8% move over the next 12 months. The stock is currently 27% below its 52-week high of $81.95, remaining 11.1% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $166.30M↑ | $147.43M↑ | $147.12M↑ | $141.96M↓ | $145.51M |
| Gross Profit | — | — | — | — | — |
| Operating Income | $41.38M↑ | $29.14M↑ | $29.04M↑ | $17.18M↓ | $44.43M |
| Net Income | $29.57M↑ | $24.76M↓ | $28.04M↑ | $26.55M↓ | $26.65M |
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. I...
Exponent, Inc. recently announced that CEO Dr. Catherine Corrigan and other senior leaders participated in a fireside chat at the Wells Fargo 16th Annual Industrials & Materials Conference, with a webcast made available via the company’s investor relations website. At the same time, bullish analyst and investor commentary has highlighted Exponent’s niche scientific expertise, capital‑light model, and disciplined capital allocation as key strengths supporting renewed interest in the...
Is EXPO a good stock to buy? We came across a bullish thesis on Exponent, Inc. on X.com by @tomicki. In this article, we will summarize the bulls’ thesis on EXPO. Exponent, Inc.’s share was trading at $60.39 as of June 1st. EXPO’s trailing and forward P/E were 28.23 and 29.33 respectively according to Yahoo Finance. Exponent […]
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how business process outsourcing & consulting stocks fared in Q1, starting with Exponent (NASDAQ:EXPO).
In late April 2026, Exponent, Inc. reported first-quarter results showing higher sales, revenue, net income and earnings per share year over year, reaffirmed high‑single‑digit revenue growth guidance for 2026, and declared a US$0.31 quarterly dividend payable on June 18, 2026. Beyond the headline beats, management highlighted strong demand for multidisciplinary consulting tied to AI integration and risk management, while also increasing its share repurchase authorization and confirming...